Cargando…

Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy

PURPOSE: To develop a model for prostate specific antigen (PSA) values at one year among patients treated with intraoperatively planned (125)I prostate brachytherapy (IOPB). MATERIAL AND METHODS: Four hundred and deven patients treated with IOPB for prostate adenocarcinoma were divided into four gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martell, Kevin, Meyer, Tyler, Sia, Michael, Angyalfi, Steve, Husain, Siraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437084/ https://www.ncbi.nlm.nih.gov/pubmed/28533796 http://dx.doi.org/10.5114/jcb.2017.67198

Ejemplares similares

Analysis of outcomes after non-contour-based dose painting of dominant intra-epithelial lesion in intra-operative low-dose rate brachytherapy()
por: Martell, Kevin, et al.
Publicado: (2020)

Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma
por: Khanolkar, Rutvij A., et al.
Publicado: (2021)

Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy
por: Hackett, Cian, et al.
Publicado: (2014)

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

MRI‐TRUS registration methodology for TRUS‐guided HDR prostate brachytherapy
por: McGeachy, Philip, et al.
Publicado: (2021)

High dose-rate brachytherapy in the treatment of prostate cancer
por: Mendez, Lucas C., et al.
Publicado: (2018)

Evaluation of intraoperative magnetic resonance imaging/ultrasound fusion optimization for low-dose-rate prostate brachytherapy
por: Abel, Stephen, et al.
Publicado: (2017)

Clinical Outcomes from Dose-Reduced Radiotherapy to the Prostate in Elderly Patients with Localized Prostate Cancer
por: Samson, Nina, et al.
Publicado: (2021)

Focal low-dose rate brachytherapy for the treatment of prostate cancer
por: Tong, William Y, et al.
Publicado: (2013)

Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options
por: Skowronek, Janusz
Publicado: (2013)

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
por: Barnes, Justin, et al.
Publicado: (2019)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

Assessment of dose to vaginal mucosa for gynecologic template interstitial high-dose-rate brachytherapy using Monte Carlo simulation
por: Elburg, Devin Van, et al.
Publicado: (2023)

Comparison of Three Groups of Patients Having Low Dose Rate Prostate Brachytherapy: Prostate-Specific Antigen Failure and Overall Survival
por: Booher, Jacquelyn, et al.
Publicado: (2021)

Dose Distribution of High Dose-Rate and Low Dose-Rate Prostate Brachytherapy at Different Intervals—Impact of a Hydrogel Spacer and Prostate Volume
por: Haddad, Hathal, et al.
Publicado: (2023)

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique
por: Morton, Gerard C.
Publicado: (2014)

A novel perineal shield for low-dose-rate prostate brachytherapy
por: Weiner, Joseph P., et al.
Publicado: (2015)

Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

Prostate specific membrane antigen positron emission tomography for lesion-directed high-dose-rate brachytherapy dose escalation
por: Smith, Christopher W., et al.
Publicado: (2021)

Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19
por: Martell, Kevin, et al.
Publicado: (2020)

Correlations of post-implant regional dosimetric parameters at 24 hours and one month, with clinical results of low-dose-rate brachytherapy for localized prostate cancer
por: Okazaki, Eiichiro, et al.
Publicado: (2017)

Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy
por: Gomez-Iturriaga, Alfonso, et al.
Publicado: (2014)

Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control
por: Mayrata, Esther, et al.
Publicado: (2021)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

Pulmonary Metastases After Low-Dose-Rate Brachytherapy for Localized Prostate Cancer
por: Kido, Masahito, et al.
Publicado: (2014)

High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective
por: Yoshioka, Yasuo, et al.
Publicado: (2014)

Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
por: Contreras, Jessika A., et al.
Publicado: (2015)

Bi‐objective optimization of catheter positions for high‐dose‐rate prostate brachytherapy
por: van der Meer, Marjolein C., et al.
Publicado: (2020)

Advantages of TRUS-based delineation for high-dose-rate prostate brachytherapy planning
por: Lavoie-Gagnon, Heloise, et al.
Publicado: (2022)

Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer
por: Nasser, Nicola J., et al.
Publicado: (2022)

The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer
por: Tanaka, Nobumichi
Publicado: (2023)

Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer
por: Tsumura, Hideyasu, et al.
Publicado: (2016)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
por: Hathout, Lara, et al.
Publicado: (2019)

Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
por: Kunogi, Hiroaki, et al.
Publicado: (2016)

Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brachytherapy
por: Wang, Yinkun, et al.
Publicado: (2015)

The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy
por: Echevarria, Michelle I., et al.
Publicado: (2016)

Evaluation of the MIM Symphony treatment planning system for low‐dose‐rate‐ prostate brachytherapy
por: Dhanesar, Sandeep K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qs1htlh790vuu313cjaf2svvd7